Mitapivat metabolically reprograms human β-thalassemic erythroblasts, increasing their responsiveness to oxidation

Abstract: β-thalassemia (β-thal) is a worldwide hereditary red cell disorder characterized by severe chronic anemia. Recently, the pyruvate kinase (PK) activator mitapivat has been shown to improve anemia and ineffective erythropoiesis in a mouse model of β-thal and in patients with non–transfusion-...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Angela Siciliano, Angelo D’Alessandro, Alessandro Matte, Giovanni Bisello, Mariarita Bertoldi, Monika Dzieciatkowska, Amy Argabright, Richard Huot Pozzetto, Veronica Riccardi, Andrea Mattarei, Alberto Ongaro, Jacopo Ceolan, Roberta Russo, Leonardo Rivadeneyra, Megan Wind-Rotolo, Achille Iolascon, Carlo Brugnara, Lucia De Franceschi
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	Elsevier 2025-06-01
Serie:	Blood Advances
Länkar:	http://www.sciencedirect.com/science/article/pii/S2473952925001636
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!